The role of surgery in primary central nervous system lymphomas
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Arquivos de neuro-psiquiatria (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000300139 |
Resumo: | ABSTRACT Background Primary central nervous system lymphomas (PCNSL) are infrequent. The traditional treatment of choice is chemotherapy. Complete resections have generally not been recommended, because of the risk of permanent central nervous system deficits with no proven improvement in survival. The aim of the current study was to compare survival among patients with PCNSL who underwent biopsy versus surgical resection. Methods A retrospective study was conducted on 50 patients with a confirmed diagnosis of PCNSL treated at our center from January 1994 to July 2015. Results Patients in the resection group exhibited significantly longer median survival time, relative to the biopsy group, surviving a median 31 months versus 14.5 months; p = 0.016. Conclusions In our series, patients who had surgical resection of their tumor survived a median 16.5 months longer than patients who underwent biopsy alone. |
id |
ABNEURO-1_f68d6a6ebcaa66f518b0510ec701323e |
---|---|
oai_identifier_str |
oai:scielo:S0004-282X2018000300139 |
network_acronym_str |
ABNEURO-1 |
network_name_str |
Arquivos de neuro-psiquiatria (Online) |
repository_id_str |
|
spelling |
The role of surgery in primary central nervous system lymphomaslymphomatherapeuticsbiopsysurvivalABSTRACT Background Primary central nervous system lymphomas (PCNSL) are infrequent. The traditional treatment of choice is chemotherapy. Complete resections have generally not been recommended, because of the risk of permanent central nervous system deficits with no proven improvement in survival. The aim of the current study was to compare survival among patients with PCNSL who underwent biopsy versus surgical resection. Methods A retrospective study was conducted on 50 patients with a confirmed diagnosis of PCNSL treated at our center from January 1994 to July 2015. Results Patients in the resection group exhibited significantly longer median survival time, relative to the biopsy group, surviving a median 31 months versus 14.5 months; p = 0.016. Conclusions In our series, patients who had surgical resection of their tumor survived a median 16.5 months longer than patients who underwent biopsy alone.Academia Brasileira de Neurologia - ABNEURO2018-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000300139Arquivos de Neuro-Psiquiatria v.76 n.3 2018reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282x20180002info:eu-repo/semantics/openAccessVillalonga,Juan FranciscoAlessandro,LucasFarez,Mauricio FrancoMormandi,RubénCervio,AndrésAlcorta,Santiago CondomíMuggeri,Alejandroeng2018-06-26T00:00:00Zoai:scielo:S0004-282X2018000300139Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2018-06-26T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse |
dc.title.none.fl_str_mv |
The role of surgery in primary central nervous system lymphomas |
title |
The role of surgery in primary central nervous system lymphomas |
spellingShingle |
The role of surgery in primary central nervous system lymphomas Villalonga,Juan Francisco lymphoma therapeutics biopsy survival |
title_short |
The role of surgery in primary central nervous system lymphomas |
title_full |
The role of surgery in primary central nervous system lymphomas |
title_fullStr |
The role of surgery in primary central nervous system lymphomas |
title_full_unstemmed |
The role of surgery in primary central nervous system lymphomas |
title_sort |
The role of surgery in primary central nervous system lymphomas |
author |
Villalonga,Juan Francisco |
author_facet |
Villalonga,Juan Francisco Alessandro,Lucas Farez,Mauricio Franco Mormandi,Rubén Cervio,Andrés Alcorta,Santiago Condomí Muggeri,Alejandro |
author_role |
author |
author2 |
Alessandro,Lucas Farez,Mauricio Franco Mormandi,Rubén Cervio,Andrés Alcorta,Santiago Condomí Muggeri,Alejandro |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Villalonga,Juan Francisco Alessandro,Lucas Farez,Mauricio Franco Mormandi,Rubén Cervio,Andrés Alcorta,Santiago Condomí Muggeri,Alejandro |
dc.subject.por.fl_str_mv |
lymphoma therapeutics biopsy survival |
topic |
lymphoma therapeutics biopsy survival |
description |
ABSTRACT Background Primary central nervous system lymphomas (PCNSL) are infrequent. The traditional treatment of choice is chemotherapy. Complete resections have generally not been recommended, because of the risk of permanent central nervous system deficits with no proven improvement in survival. The aim of the current study was to compare survival among patients with PCNSL who underwent biopsy versus surgical resection. Methods A retrospective study was conducted on 50 patients with a confirmed diagnosis of PCNSL treated at our center from January 1994 to July 2015. Results Patients in the resection group exhibited significantly longer median survival time, relative to the biopsy group, surviving a median 31 months versus 14.5 months; p = 0.016. Conclusions In our series, patients who had surgical resection of their tumor survived a median 16.5 months longer than patients who underwent biopsy alone. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-03-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000300139 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000300139 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/0004-282x20180002 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
dc.source.none.fl_str_mv |
Arquivos de Neuro-Psiquiatria v.76 n.3 2018 reponame:Arquivos de neuro-psiquiatria (Online) instname:Academia Brasileira de Neurologia instacron:ABNEURO |
instname_str |
Academia Brasileira de Neurologia |
instacron_str |
ABNEURO |
institution |
ABNEURO |
reponame_str |
Arquivos de neuro-psiquiatria (Online) |
collection |
Arquivos de neuro-psiquiatria (Online) |
repository.name.fl_str_mv |
Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia |
repository.mail.fl_str_mv |
||revista.arquivos@abneuro.org |
_version_ |
1754212783674621952 |